Global Circulating Tumor Cells Market Poised for Significant Growth: Projected to Reach $41.27 Billion by 2033

The global circulating tumor cells (CTCs) market size valued at approximately US$ 11.49 billion in 2023, is set for substantial expansion, with projections indicating it will reach US$ 41.27 billion by 2033. This growth represents a compound annual growth rate (CAGR) of 13.64% from 2024 to 2033, driven primarily by the rising prevalence of cancer.

Circulating tumor cells are cancer cells that have detached from their primary tumor and entered the bloodstream, making them crucial targets for understanding and combating cancer metastasis. The rapid growth of the CTC market is fueled by advancements in CTC detection technologies, which have enhanced our understanding of these cells and facilitated their use in clinical settings. These advancements support various applications, including prognosis assessment, treatment response monitoring, and cancer screening, thus accelerating research and therapeutic opportunities in oncology.

Circulating Tumor Cells Market TOC | Table of Content

Introduction

• Definition and Scope
• Methodology
• Assumptions and Limitations

Executive Summary

• Market Snapshot
• Key Findings
• Market Dynamics Overview

Market Overview

• Market Drivers
• Market Restraints
• Market Opportunities
• Market Trends
• Value Chain Analysis
• Porter’s Five Forces Analysis

Circulating Tumor Cells Market Analysis

• Market Size and Forecast (Value and Volume)
• Market Share Analysis
• Competitive Landscape

Segmentation Analysis

• By Technology
  • CTC Detection & Enrichment Methods
    • Immunocapture (Label-based)
      • Positive Selection
      • Negative Selection
    • Size-based Separation (Label-free)
      • Membrane-based
      • Microfluidic-based
    • Density-based Separation (Label-free)
    • Combined Methods
  • CTC Direct Detection Methods
    • SERS
    • Microscopy
    • Others
  • CTC Analysis
• By Application
  • Clinical/ Liquid Biopsy
    • Risk Assessment
    • Screening and Monitoring
  • Research
    • Cancer Stem Cell & Tumorogenesis Research
    • Drug/Therapy Development
• By Product
  • Kits & Reagents
  • Blood Collection Tubes
  • Devices or Systems
• By Specimen
  • Blood
  • Bone Marrow
  • Other Body Fluids
• By Regional
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa (MEA)

Cross Sectional Segmentations Analysis

By Technology

• CTC Detection & Enrichment Methods
  • Immunocapture (Label-based)
    • Positive Selection
      • Value and Volume: Analysis of market value and volume specifically for technologies that isolate CTCs by using antibodies targeting specific cell surface markers.
      • Applications: Used for isolating rare cancer cells from blood samples with high specificity.
    • Negative Selection
      • Value and Volume: Market analysis for methods that remove non-CTCs from the sample while leaving CTCs intact.
      • Applications: Useful for reducing background noise in samples and increasing CTC purity.
  • Size-based Separation (Label-free)
    • Membrane-based
      • Value and Volume: Market share of membrane-based filtration systems that separate cells based on size differences.
      • Applications: Effective in environments where label-based methods are impractical.
    • Microfluidic-based
      • Value and Volume: Market analysis for microfluidic devices that use channels and forces to separate CTCs by size.
      • Applications: Enables high-throughput, high-resolution separation of cells in a miniaturized format.
    • Density-based Separation (Label-free)
      • Value and Volume: Market value for methods based on density gradients to isolate CTCs.
      • Applications: Common in protocols where separation is based on the physical density of the cells.
  • Combined Methods
    • Value and Volume: Analysis of the market for techniques that integrate multiple separation strategies (e.g., combining immunocapture with size-based separation).
    • Applications: Aims to enhance the accuracy and yield of CTC isolation by leveraging the strengths of different methods.
  • CTC Direct Detection Methods
    • SERS (Surface-Enhanced Raman Spectroscopy)
      • Value and Volume: Market value for SERS techniques used to detect and identify CTCs based on their unique Raman spectra.
      • Applications: Provides a non-invasive and highly sensitive method for detecting CTCs.
    • Microscopy
      • Value and Volume: Market share of microscopy methods for direct observation and enumeration of CTCs.
      • Applications: Includes fluorescence microscopy, bright-field microscopy, and more for visualizing CTCs.
  • Others
    • Value and Volume: Includes other direct detection technologies, such as electrochemical methods or nanoparticle-based detection.
• CTC Analysis
  • Value and Volume: Market analysis for the various methods used to analyze CTCs after isolation.
  • Types of Analysis:
    • Molecular (RNA, DNA) Analysis: Techniques used to study genetic material of CTCs for understanding tumor biology and mutations.
    • Protein-Based Analysis: Methods for analyzing proteins expressed on CTCs to gain insights into cell signaling and interaction.

By Application

• Clinical/ Liquid Biopsy
  • Risk Assessment
    • Value and Volume: Market analysis for using CTCs to assess the risk of cancer progression or recurrence.
    • Applications: Includes monitoring disease status and predicting patient outcomes.
  • Screening and Monitoring
    • Value and Volume: Market share of CTCs in routine screening and monitoring of cancer.
    • Applications: Regular testing of patients to track tumor burden and response to treatment.
• Research
  • Cancer Stem Cell & Tumorogenesis Research
    • Value and Volume: Market value for using CTCs in research focused on cancer stem cells and tumor development mechanisms.
    • Applications: Investigating the role of CTCs in cancer progression and metastasis.
  • Drug/Therapy Development
    • Value and Volume: Analysis of CTCs in the development of new cancer therapies and drug testing.
    • Applications: Evaluating therapeutic efficacy and resistance mechanisms.

By Product

• Kits & Reagents
  • Value and Volume: Market analysis for commercial kits and reagents used for CTC detection, enrichment, and analysis.
  • Types:
    • Isolation Kits: For the separation of CTCs from blood samples.
    • Detection Reagents: For identifying and quantifying CTCs.
• Blood Collection Tubes
  • Value and Volume: Market value for specialized blood collection tubes designed for preserving CTCs.
  • Types:
    • Tube Types: Includes tubes with additives to prevent CTC degradation.
• Devices or Systems
  • Value and Volume: Market share of automated or manual devices used for CTC isolation and analysis.
  • Types:
    • Automated Systems: For high-throughput CTC processing.
    • Manual Devices: Lab equipment used for CTC handling and examination.

By Specimen

• Blood
  • Value and Volume: Market analysis for CTCs isolated from blood samples.
  • Applications: The most common specimen type used for CTC detection and analysis.
• Bone Marrow
  • Value and Volume: Market share for CTC analysis using bone marrow specimens.
  • Applications: Used in specific types of cancer where bone marrow involvement is significant.
• Other Body Fluids
  • Value and Volume: Analysis of CTCs in fluids such as cerebrospinal fluid or pleural effusions.
  • Applications: Relevant for cancers affecting multiple body systems.

By Regional

• North America
  • U.S. (Value and Volume)
  • Canada (Value and Volume)
• Europe
  • Germany (Value and Volume)
  • UK (Value and Volume)
  • France (Value and Volume)
  • Italy (Value and Volume)
  • Spain (Value and Volume)
  • Sweden (Value and Volume)
  • Denmark (Value and Volume)
  • Norway (Value and Volume)
• Asia Pacific
  • China (Value and Volume)
  • Japan (Value and Volume)
  • India (Value and Volume)
  • South Korea (Value and Volume)
  • Australia (Value and Volume)
  • Thailand (Value and Volume)
• Latin America
  • Brazil (Value and Volume)
  • Mexico (Value and Volume)
  • Argentina (Value and Volume)
• Middle East and Africa (MEA)
  • South Africa (Value and Volume)
  • UAE (Value and Volume)
  • Saudi Arabia (Value and Volume)
  • Kuwait (Value and Volume)

Competitive Landscape

• Company Market Share Analysis
• Key Company Profiles
  • STEMCELL Technologies, Inc.
    • Overview
    • Product Portfolio
    • Financial Performance (Value and Volume)
    • Recent Developments
  • Immunocore
  • Sysmex Corporation
  • Merck & Co.
  • BioCEP Ltd.
  • BIOCEPT, Inc.
  • Ikonisys, Inc.
  • IVDiagnostics, Inc.
  • Miltenyi Biotec
  • BioFluidica
  • AVIVA Biosciences
  • Fluxion Biosciences, Inc.
  • Canopus Bioscience Ltd.
  • Precision for Medicine
  • Bio-Techne Corporation
  • LungLife AI, Inc.
  • Greiner Bio-One International GmbH
  • ScreenCell
  • Biolidics Limited
  • Rarecells Diagnostics
  • Creativ MicroTech, Inc.
  • LineaRx, Inc. (Vitatex, Inc.)
  • Menarini Silicon Biosystems
  • Epic Sciences
  • QIAGEN

Market Outlook

• Future Market Trends
• Strategic Recommendations

Appendix

• Research Methodology
• About Us
• Disclaimer

To own our research study instantly, Click here @ https://www.towardshealthcare.com/price/5172

You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

About Us

Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations.

Explore the comprehensive statistics and insights on healthcare industry data and its associated segmentation: Get a Subscription

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare